tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CVS Group Backs DEFRA Consultation on Overhaul of Veterinary Surgeons Act

Story Highlights
  • CVS Group welcomes DEFRA’s consultation to reform the outdated Veterinary Surgeons Act, following CMA recommendations.
  • The company expects regulatory reform to strengthen practice standards while confirming FY2026 results remain on track.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group Backs DEFRA Consultation on Overhaul of Veterinary Surgeons Act

Claim 50% Off TipRanks Premium

CVS Group plc ( (GB:CVSG) ) just unveiled an update.

CVS Group has welcomed the UK Government’s decision to launch an eight-week consultation on reforms to the Veterinary Surgeons Act 1966, a move that stems from recommendations made by the Competition and Markets Authority following its market investigation into household pet veterinary services. The company, which has long advocated modernisation of the Act, argues that reform will bolster consumer confidence, introduce stronger practice-level regulation such as mandatory adherence to the Practice Standards Scheme, and expand the role of Registered Veterinary Nurses to perform a broader range of procedures; CVS also reaffirmed that it expects to deliver its FY2026 results in line with the board’s expectations, signalling operational stability as regulatory changes are explored.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1431.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is a leading provider of veterinary services with operations in the UK and Australia, focused on delivering high-quality clinical care to clients and their animals. The Group operates around 470 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also runs diagnostic laboratories and an online retail business, employing approximately 8,900 staff, among them about 2,500 veterinary surgeons and 3,300 nurses and patient care assistants.

Average Trading Volume: 613,018

Technical Sentiment Signal: Buy

Current Market Cap: £935.2M

See more insights into CVSG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1